Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study

Critical Care Medicine

Volumn 39, Issue 3, 2011, Pages 450-455

  Levy, Bruno ^a,b   Perez, Pierre ^a   Perny, Jessica ^a   Thivilier, Carine ^a   Gerard, Alain ^a  

^a CHU NANCY BRABOIS   (France)

^b INSERM   (France)

Author keywords

cardiogenic shock; dobutamine; epinephrine; lactate; norepinephrine

Indexed keywords

ADRENALIN; AMIODARONE; CREATININE; DOBUTAMINE; DOPAMINE; LACTIC ACID; NORADRENALIN; PYRUVIC ACID; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTERIAL PH; ARTICLE; CARBON DIOXIDE TENSION; CARDIOGENIC SHOCK; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIURESIS; DRUG DOSE TITRATION; ELECTROCARDIOGRAM; FEMALE; GASTRIC MUCOSA PERFUSION; HEART INDEX; HEART INFARCTION; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; MONOTHERAPY; OPEN STUDY; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN TRANSPORT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STOMACH MUCOSA; TISSUE PERFUSION; TONOMETRY;

EID: 79952157228     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181ffe0eb     Document Type: Article

References (18)

1. Antman EM, Anbe DT, Armstrong PW, et al: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 2004; 44: E1-E211.
2. Topalian S, Ginsberg F, Parrillo JE: Cardiogenic shock. Crit Care Med 2008; 36(Suppl 1):S66-S74.
3. Reynolds HR, Hochman JS: Cardiogenic shock: Current concepts and improving outcomes. Circulation 2008; 117:686-697.
4. De Backer D, Biston P, Devriendt J, et al: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779-789.
5. Hochman JS: Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003; 107: 2998-3002. (Pubitemid 36758968)
6. Annane D, Vignon P, Renault A, et al: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet 2007; 370: 676-684. (Pubitemid 47299251)
7. Levy B, Bollaert PE, Charpentier C, et al: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997; 23: 282-287. (Pubitemid 27129993)
8. Levy B, Gawalkiewicz P, Vallet B, et al: Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients. Crit Care Med 2003; 31:474-480. (Pubitemid 36232943)
9. Levy B, Sadoune LO, Gelot AM, et al: Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine- treated septic shock. Crit Care Med 2000; 28:114-119. (Pubitemid 30091039)
10. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, et al: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29:2388-2442.
11. Iakobishvili Z, Hasdai D: Cardiogenic shock: Treatment. Med Clin North Am 2007; 91: 713-727; xii. (Pubitemid 47058137)
12. Ensinger H, Weichel T, Lindner KH, et al: Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient? Intensive Care Med 1995; 21:50-56.
13. Nikolaidis LA, Hentosz T, Doverspike A, et al: Catecholamine stimulation is associated with impaired myocardial O(2) utilization in heart failure. Cardiovasc Res 2002; 53:392-404. (Pubitemid 34117690)
14. Levy B, Mansart A, Bollaert PE, et al: Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats. Intensive Care Med 2003; 29:292-300. (Pubitemid 36384420)
15. Levy B, Gibot S, Franck P, et al: Relation between muscle Na KAT Pase activity and raised lactate concentrations in septic shock: A prospective study. Lancet 2005; 365: 871-875. (Pubitemid 40332165)
16. Takala J: Determinants of splanchnic blood flow. Br J Anaesth 1996; 77:50-58. (Pubitemid 26229912)
17. Jakob SM, Takala J: Gut perfusion in the critically ill. Intensive Care Med 2000; 26: 813-815. (Pubitemid 30449680)
18. Aymong ED, Ramanathan K, Buller CE: Pathophysiology of cardiogenic shock complicating acute myocardial infarction. Med Clin North Am 2007; 91:701-712; xii (Pubitemid 47058141)